| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 11.4 | 12.3 | 12.3 |
| Other income | 0.1 | 0.1 | 0.1 |
| Total income | 11.5 | 12.4 | 12.4 |
| Profit before exceptional items & tax | 0.7 | 1.1 | 1.0 |
| Exceptional items | 0.5 | 0.0 | 0.0 |
| Profit before tax | 0.2 | 1.1 | 1.0 |
| Net profit | 0.1 | 0.7 | -3.4 |
| Operating margin | 1.7% | 8.9% | 8.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -85.70% |
|---|---|
| Revenue, year on year | -7.30% |
BSE results filing, NSE: GUJTERC. Figures extracted from the filing.
Gujarat Terce Laboratories Ltd: key numbers
- Share price
- ₹37.81
- Market cap
- ₹28.06 Cr
- Revenue (annual)
- ₹47.47 Cr
- Net profit (annual)
- ₹2.20 Cr
- P/E (TTM)
- 13.4×Sector 47.4×
- Promoter holding
- 40.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Terce Laboratories Ltd
All →Gujarat Terce Laboratories Annual General Meeting
Gujarat Terce Laboratories held its 41st Annual General Meeting on August 21, 2026. Members passed resolutions regarding financial statements and director re-appointments.
Gujarat Terce Laboratories Management Change
Gujarat Terce Laboratories issued a corrigendum clarifying the re-appointment tenure of its MD & CEO, Mr. Aalap Prajapati, as three years instead of five.
Gujarat Terce Laboratories Q1 FY27 Results: Net Loss of ₹0.2 Cr
Gujarat Terce Laboratories Ltd reported revenue from operations of ₹9 Cr (-17.4% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.2 Cr
Gujarat Terce Laboratories Board Meeting Date
Gujarat Terce Laboratories will hold a board meeting on 7 August 2026 to approve the unaudited standalone financial results for the quarter ended 30 June 2026.
Gujarat Terce Laboratories Annual Report
Gujarat Terce Laboratories Ltd has filed its Annual Report for the financial year 2025-26 and notice of its 41st Annual General Meeting.
Gujarat Terce Laboratories Other Announcement
Gujarat Terce Laboratories Ltd filed its shareholding pattern as of June 30, 2026, detailing promoter, promoter group and public holdings. No monetary transaction is disclosed.